Business Segment Information

12 Months Ended

Dec. 31, 2023

Segment Reporting [Abstract]

Business Segment Information

23. Business Segment Information

The Company has four reportable segments, BSI BioSpin, BSI CALID, BSI Nano and BEST, as discussed in Note 1 to the consolidated financial statements. The Company's CEO is the chief operating decision maker.

Selected reportable segment information is presented below (in millions):

	2023			2022			2021
Revenue:
BSI BioSpin	$	798.5		$	696.7		$	691.0
BSI CALID		960.4			822.2			819.6
BSI Nano		941.9			787.0			697.5
BEST		280.7			237.1			223.8
Eliminations (a)		(17.0	)		(12.3	)		(14.0	)
Total revenue	$	2,964.5		$	2,530.7		$	2,417.9
Operating Income:
BSI BioSpin	$	195.9		$	167.1		$	158.2
BSI CALID		209.3			196.0			227.2
BSI Nano		109.1			113.0			73.4
BEST		32.3			31.3			22.2
Corporate, eliminations and other (b)		(109.7	)		(74.7	)		(67.7	)
Total operating income	$	436.9		$	432.7		$	413.3

(a)Represents product and service revenue between reportable segments.

(b)Represents corporate costs and eliminations not allocated to the reportable segments.

Total assets by segment are as follows (in millions):

	2023			2022
Assets:
BSI BioSpin, BSI CALID, BSI Nano & Corporate	$	4,110.6		$	3,508.4
BEST		186.0			111.1
Eliminations and other (a)		(46.7	)		(7.7	)
Total assets	$	4,249.9		$	3,611.8

(a)Assets not allocated to the reportable segments and eliminations of intercompany transactions.

The Company is unable, without unreasonable effort or expense to disclose the amount of total assets by the BSI BioSpin, BSI CALID and BSI Nano Segments as well as the Corporate function and further, the Company’s chief operating decision maker does not receive any asset information by operating segment.

Total capital expenditures and depreciation and amortization by segment are presented below (in millions):

	2023		2022		2021
Capital Expenditures:
BSI BioSpin	$	23.9	$	14.5	$	36.6
BSI CALID		31.4		33.9		24.7
BSI Nano		13.9		20.2		16.8
Corporate		10.2		9.1		4.7
BEST		27.5		51.5		9.2
Total capital expenditures	$	106.9	$	129.2	$	92.0
Depreciation and Amortization:
BSI BioSpin	$	25.7	$	22.6	$	21.3
BSI CALID		29.3		20.7		19.8
BSI Nano		48.0		35.6		37.4
Corporate		4.7		3.9		4.3
BEST		7.2		6.0		6.3
Total depreciation and amortization	$	114.9	$	88.8	$	89.1

Revenue and long-lived assets (including property, plant and equipment, net and operating lease right of use assets) by geographical area are as follows (in millions):

	2023		2022		2021
Revenue:
United States	$	777.7	$	696.1	$	601.0
Germany		281.5		247.4		262.6
Rest of Europe		699.7		591.9		658.1
China		528.1		396.5		357.6
Rest of Asia Pacific		460.9		408.4		371.5
Other		216.6		190.4		167.1
Total revenue	$	2,964.5	$	2,530.7	$	2,417.9

	2023		2022		2021
Long-lived assets:
Germany	$	350.2	$	309.6	$	244.0
Switzerland		127.0		98.5		96.3
United States		124.9		58.8		51.3
Rest of Europe		57.4		42.5		45.2
Asia Pacific		22.1		22.1		22.6
Other		9.9		6.7		6.6
Total long-lived assets	$	691.5	$	538.2	$	466.0